Neuroscience Market Analysis and Reports | Japan Conference Series

Market Analysis - Neuroscience 2017

Theme: Neuroscience across the Lifespan, Amelioration of Neuroscience




Neuroscience 2017 welcomes attendees, presenters, and exhibitors from all over the world to Melbourne, Australia. We are delighted to invite you all to attend and register for the“17th Global Neuroscience conference” which is going to be held during October 16-17, 2017 in Osaka Japan.


The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuroscience 2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Neuroscience 2017 organizing committee look forward to meeting you in Osaka, Japan.


For more details please visit-


Importance and Scope:


Global neuroscience industry demand was worth USD 24.09 Billion in 2013 and is anticipated to reach above USD 30.80 billion by 2020. Rising investment in R&D resulting in the development of numerous products in the neuro informatics coupled with adequate funding from the government are key factors that drive growth in this market.


Neuro-informatics involve designing and developing efficient tools and algorithms that can augment the performance of structural and functional mapping. Global Neuroscience market is expected to grow at CAGR of 2.9% over the next seven years.


Increasing occurrence of malicious disorders including Parkinsonism and Alzheimer’s disease together with other inherited CNS disorders has resulted in increased necessity for new improvements in neuroscience industry. The market is expected to experience growth over the forecast period on account of growing demand in laboratories and academic centres. The market players aim at introducing unique technologies with the ability to obtain insights to understand better the compound nervous functionalities and neural manipulations. Furthermore, increasing aggregate geriatric population every year is anticipated to drive significantly the demand owing to a growing need for better treatment and medication.


Why in Osaka:


Osaka is the second largest Metropolitan area in Japan. Aggrandize in the multitude of people experiencing psychological issues exonerate the endurance of 40 associations and societies affiliated to Neuroscience in Osaka and Japan. Japan is displacing towards contemporary psychology industry from its traditional “shinrigaku”.


Also known as the “Nation’s Kitchen”, Osaka is a major economic hub, hosting nearly 19million people. The GDP in Osaka is about $341 Billion. Along with Paris and London, it is one of the most productive hinterlands in the world. Osaka is the second most expensive city for expatriate employees in the world 2009.


Osaka is known for its modern architecture, nightlife and hearty street food. The 16th Century Osaka Castle is the major attraction in this city along with the bustling Umeda Underground Mall and Namba Park.


Conference Highlights:


Ø  Neurological disorders


Ø  Cognitive neuroscience


Ø  Neurobiology of CNS


Ø  Clinical Neuro-surgery


Ø  Neuro-oncology


Ø  Neuro-degenerative disorders


Ø  Neuro-physiology


Ø  Neuro-genetics


Ø  Neuro-chemistry


Ø  Neuro-informatics


Ø  Neuro-immunology


Ø  Neuro-Ophthalmology


Ø  Neuro-pharmacology


Ø  Neuro-toxicology


Ø  Neuro-psychiatry


Ø  Neuro-rehabilitation


Ø  Neurological Nursing


Ø  Neuro-critical Care


Ø  Novel Therapeutics


Why to attend???


15th Global Neuroscience Conference is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.


Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Neuroscience


A Unique Opportunity for Advertisers and Sponsors at this International event:


For more details please visit-


Companies Associated with Psychology in Japan are


Following are the some companies in Japan which produces antipsychotic drugs they are:


     Ø  Pfizer


     Ø  GlaxoSmithKline


     Ø  Solvay of Belgium


     Ø  Fujisawa Pharmaceutical


     Ø  Meiji Seika


     Ø  Janssen Pharmaceutical


     Ø  Lund beck


     Ø  Asahi Kasei Corporation


     Ø  Forest Laboratories


     Ø  Eli Lilly


     Ø  Wyeth Pharmaceuticals


     Ø  Organon International






§  Aino University


§   Hagoromo International University


§   Hannan University


§  Heian Jogakuin-St. Agnes'-University


§  Kansai Medical University


§   Kinki University


§  Kwansei Gakuin University, Osaka-Umeda


§  Morinomiya University of Medical Sciences


§  Osaka Kawasaki Rehabilitation University


§  Osaka University of Human Sciences


§  Soai University


§  Tokiwakai Gakuen University




·         Osaka University Hospital


·         Kosei Nenkin Hospital


·         Sumitomo Hospital


·         Yodogawa Christian Hospital


·         Wada Hospital


·         Ueda Surgery Hospital